| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XNSE Exchange | Y3195T157 CUSIP |
| India Country | 2,061 Employees | 17 Feb 2026 Last Dividend | 22 Jun 2018 Last Split | - IPO Date |
Hikal Limited, along with its subsidiaries, stands as a pivotal manufacturer and seller of a wide range of chemical intermediates, specialty chemicals, and active pharmaceutical ingredients (APIs). The company serves a diverse clientele across the pharmaceutical, animal health, biotech, crop protection, and specialty chemicals sectors. Boasting an extensive international presence, Hikal Limited caters to markets in India, the United States, Canada, Europe, South East Asia, among others. Operating under two main segments, Pharmaceuticals and Crop Protection, the company has shown a commitment to innovation and quality. Pharmaceuticals segment focuses on producing active pharmaceutical ingredients, whereas the Crop Protection segment is dedicated to the manufacturing of pesticides and herbicides. Originally named Hikal Chemical Industries Ltd., it underwent a rebranding to Hikal Limited in April 2000. Since its inception in 1988, Hikal Limited has established its headquarters in Navi Mumbai, India and has continued to expand its global footprint through both direct exports and strategic collaborations.
These are pivotal for the pharmaceutical sector, enabling the creation of a wide array of medicines. Hikal Limited specializes in the production of APIs used in various therapeutics, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic drugs.
Key offerings include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. These products are essential for crop protection, aiding in the control of pests and diseases to ensure healthy crop yields.
Hikal offers a range of products for animal health care including anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID products, catering to the well-being of animals.
These substances are designed for use in various industrial applications, including leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. They play a crucial role in preventing microbial growth and ensuring the durability and safety of products.
In addition to its extensive product portfolio, Hikal Limited offers tailored solutions in contract research, custom synthesis, and custom manufacturing. This involves collaborating with other companies to develop and manufacture intermediates and active ingredients, thus enhancing innovation and meeting specific customer needs.